Stimcell Energetics (STME) Total Debt Growth (3y) (2016 - 2023)
Stimcell Energetics (STME) Total Debt Growth (3y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.11% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.61% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -0.32% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.42% |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2023 | -66.32% |
| Aug 31, 2023 | -49.40% |
| May 31, 2023 | -39.18% |
| Feb 28, 2023 | -39.84% |
| Nov 30, 2022 | -42.98% |
| Aug 31, 2022 | -34.56% |
| May 31, 2022 | -50.16% |
| Feb 28, 2022 | 58.41% |
| Nov 30, 2021 | 55.75% |
| Aug 31, 2021 | 52.10% |
| May 31, 2021 | 26.92% |
| Feb 28, 2021 | 72.49% |
| Nov 30, 2020 | 76.09% |
| Aug 31, 2020 | 53.27% |
| May 31, 2020 | 29.01% |
| Feb 29, 2020 | 26.09% |
| May 31, 2019 | 42.78% |
| May 31, 2017 | 159.38% |
| May 31, 2016 | 188.24% |